Literature DB >> 18524948

Integrins in prostate cancer progression.

Hira Lal Goel1, Jing Li, Sophia Kogan, Lucia R Languino.   

Abstract

Integrins, which are transmembrane receptors for extracellular matrix proteins, play a key role in cell survival, proliferation, migration, gene expression, and activation of growth factor receptors. Their functions and expression are deregulated in several types of cancer, including prostate cancer. In this article, we review the role of integrins in prostate cancer progression and their potential as therapeutic targets.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18524948      PMCID： PMC2668544          DOI： 10.1677/ERC-08-0019

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


  76 in total

Review 1.  Integrin adhesion receptors in tumor metastasis.

Authors:  Brunhilde Felding-Habermann
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

2.  The role of PTEN in prostate cancer cell tropism to the bone micro-environment.

Authors:  Z Wu; K S McRoberts; D Theodorescu
Journal:  Carcinogenesis       Date:  2007-03-07       Impact factor: 4.944

3.  Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.

Authors:  Jun-Li Luo; Wei Tan; Jill M Ricono; Olexandr Korchynskyi; Ming Zhang; Steven L Gonias; David A Cheresh; Michael Karin
Journal:  Nature       Date:  2007-03-18       Impact factor: 49.962

Review 4.  Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Carcinogenesis       Date:  2005-09-29       Impact factor: 4.944

5.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Authors:  Catherine C Park; Hui Zhang; Maria Pallavicini; Joe W Gray; Frederick Baehner; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

6.  Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6.

Authors:  Janeen Azare; Kenneth Leslie; Hikmat Al-Ahmadie; William Gerald; Paul H Weinreb; Shelia M Violette; Jacqueline Bromberg
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

Review 7.  Current status of anti-angiogenesis therapy for prostate cancer.

Authors:  Juan Antonio Jiménez; Chinghai Kao; Sudhanshu Raikwar; Thomas A Gardner
Journal:  Urol Oncol       Date:  2006 May-Jun       Impact factor: 3.498

8.  Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.

Authors:  Xiaohua Li; Di Chen; Shuping Yin; Yonghong Meng; Huanjie Yang; Kristin R Landis-Piwowar; Yiwei Li; Fazlul H Sarkar; G Prem Veer Reddy; Q Ping Dou; Shijie Sheng
Journal:  J Cell Physiol       Date:  2007-08       Impact factor: 6.384

9.  Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.

Authors:  Baoguo Ren; Yan P Yu; George C Tseng; Chuanyue Wu; Ka Chen; Uma N Rao; Joel Nelson; George K Michalopoulos; Jian-Hua Luo
Journal:  J Natl Cancer Inst       Date:  2007-06-06       Impact factor: 13.506

10.  Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration.

Authors:  Thomas Manes; Duo-Qi Zheng; Simona Tognin; Amy S Woodard; Pier Carlo Marchisio; Lucia R Languino
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539
View more
  81 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

2.  Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.

Authors:  Claudia Fredolini; Francesco Meani; Alessandra Luchini; Weidong Zhou; Paul Russo; Mark Ross; Alexis Patanarut; Davide Tamburro; Guido Gambara; David Ornstein; Franco Odicino; Monica Ragnoli; Antonella Ravaggi; Francesco Novelli; Devis Collura; Leonardo D'Urso; Giovanni Muto; Claudio Belluco; Sergio Pecorelli; Lance Liotta; Emanuel F Petricoin
Journal:  AAPS J       Date:  2010-06-12       Impact factor: 4.009

3.  PSA regulates androgen receptor expression in prostate cancer cells.

Authors:  Parmita Saxena; Marco Trerotola; Tao Wang; Jing Li; Aejaz Sayeed; Jennifer Vanoudenhove; Dave S Adams; Thomas J Fitzgerald; Dario C Altieri; Lucia R Languino
Journal:  Prostate       Date:  2011-09-28       Impact factor: 4.104

4.  Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.

Authors:  Amrita Singh; Carmine Fedele; Huimin Lu; Marja T Nevalainen; James H Keen; Lucia R Languino
Journal:  Mol Cancer Res       Date:  2016-07-20       Impact factor: 5.852

5.  Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.

Authors:  Hira Lal Goel; Jean M Underwood; Jeffrey A Nickerson; Chung-Cheng Hsieh; Lucia R Languino
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

6.  Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells.

Authors:  Corey L Neal; Danielle Mckeithen; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

7.  SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Authors:  Jenna D Lovaas; Lijia Zhu; Christine Y Chiao; Vanessa Byles; Douglas V Faller; Yan Dai
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

8.  Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization.

Authors:  Afshin Varzavand; Justin M Drake; Robert U Svensson; Mary E Herndon; Bo Zhou; Michael D Henry; Christopher S Stipp
Journal:  Clin Exp Metastasis       Date:  2012-12-06       Impact factor: 5.150

9.  Aberrant BAF57 signaling facilitates prometastatic phenotypes.

Authors:  Sucharitha Balasubramaniam; Clay E S Comstock; Adam Ertel; Kwang Won Jeong; Michael R Stallcup; Sankar Addya; Peter A McCue; William F Ostrander; Michael A Augello; Karen E Knudsen
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531

10.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.